{"doc_desc":{"title":"\u00c9tude \u00c9pid\u00e9miologique aupr\u00e8s de femmes de la Mutuelle G\u00e9n\u00e9rale de l\u2019\u00c9ducation Nationale (MGEN)","idno":"FRESH-PEF3162-fr","producers":[{"name":"CAMILLE LAPLANCHE","affiliation":""}]},"study_desc":{"title_statement":{"idno":"FRESH-PEF3162-fr","IDno":{"metadata_no":[{"agency":"Portail \u00c9pid\u00e9miologie France (PEF)","code":"3162"},{"agency":"FReSH","code":"FRESH-PEF3162"}],"metadata_yes":[{"code":"FReSH","agency":"FReSH"}]},"title":"\u00c9tude \u00c9pid\u00e9miologique aupr\u00e8s de femmes de la Mutuelle G\u00e9n\u00e9rale de l\u2019\u00c9ducation Nationale (MGEN)","alternate_title":"Cohorte E3N"},"study_authorization":{"agency":[{"name":"CNIL"},{"name":"CPP"}]},"authoring_entity":[{"name":"Gianluca;SEVERI","firstname":"Gianluca","lastname":"SEVERI","type":"investigator","extlink":[{"title":"ORCID","uri":"0000-0001-7157-419X","role":"pi id"},{"title":"IdRef","uri":"198040598","role":"pi id"},{"title":"SIREN","uri":"180036048","role":"organisation id"},{"title":"ROR","uri":"https:\/\/ror.org\/02vjkv261","role":"organisation id"},{"title":"RNSR","uri":"201019083D ","role":"labo id"}],"email":"gianluca.severi@inserm.fr","affiliationName":"INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)","PILabo":"Centre de Recherche en \u00c9pid\u00e9miologie et Sant\u00e9 des Populations (CESP) - \u00c9quipe Exposome et H\u00e9r\u00e9dit\u00e9\n\nInserm, Universit\u00e9 Paris-Saclay, Institut Gustave Roussy ","isContact":false}],"oth_id":[{"name":";","firstname":"","lastname":"","type":"contributor","isContact":"","extlink":[{"title":"ORCID","uri":"","role":"team member id"},{"title":"IdRef","uri":"","role":"team member id"}]},{"name":"","type":"affiliation","teamMemberLabo":"","extlink":[{"title":"RNSR","uri":"","role":"labo id"}]},{"name":"La cohorte europ\u00e9enne EPIC (European Prospective Investigation into Cancer and Nutrition), dont la partie fran\u00e7aise est repr\u00e9sent\u00e9e par la cohorte E3N. Les consortia ELAPSE, EPITHYR, LIFEPATH et ESCAPE utilisent \u00e9galement des donn\u00e9es de la cohorte E3N. Les donn\u00e9es E3N sont \u00e9galement utilis\u00e9es dans l'\u00e9tude nationale SAPRIS sur le covid-19.","type":"collaboration"}],"production_statement":{"prod_place":"Portail Epid\u00e9miologie France (PEF)","producers":[{"name":"INSTITUT GUSTAVE ROUSSY (IGR)","role":"sponsor","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/0321g0743","role":"sponsor id"},{"title":"SIREN","uri":"775741101","role":"sponsor id"}]},{"name":"INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)","role":"sponsor","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/02vjkv261","role":"sponsor id"},{"title":"SIREN","uri":"180036048","role":"sponsor id"}]},{"name":"UNIVERSITE PARIS-SACLAY","role":"sponsor","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/03xjwb503","role":"sponsor id"},{"title":"SIREN","uri":"130026024","role":"sponsor id"}]}],"funding_agencies":[{"name":"MINISTERE DE L\u2019ENSEIGNEMENT SUPERIEUR, DE LA RECHERCHE ET DE L\u2019ESPACE","extlink":[{"title":"SIREN","uri":"110044013"},{"title":"ROR","uri":"https:\/\/ror.org\/03sjk9a61"}]},{"name":"INSTITUT GUSTAVE ROUSSY (IGR)","extlink":[{"title":"SIREN","uri":"775741101"},{"title":"ROR","uri":"https:\/\/ror.org\/0321g0743"}]},{"name":"MUTUELLE GENERALE DE L EDUCATION NATIONALE (MGEN)","extlink":[{"title":"SIREN","uri":"444268627"}]},{"name":"INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/02vjkv261"},{"title":"SIREN","uri":"180036048"}]},{"name":"LIGUE NATIONALE CONTRE LE CANCER (LNCC)","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/00rkrv905"},{"title":"SIREN","uri":"775664717"}]},{"name":"AGENCE NATIONALE DE LA RECHERCHE (ANR)","extlink":[{"title":"SIREN","uri":"130002504"},{"title":"ROR","uri":"https:\/\/ror.org\/00rbzpz17"}]}]},"distribution_statement":{"contact":[{"name":"Elodie;SPEYER","lastname":"SPEYER","firstname":"Elodie","type":"contact","email":"elodie.speyer@inserm.fr","affiliationName":"UNIVERSITE PARIS-SACLAY","contactPointLabo":"Centre de Recherche en \u00c9pid\u00e9miologie et Sant\u00e9 des Populations (CESP) - \u00c9quipe Exposome et H\u00e9r\u00e9dit\u00e9\n\nInserm, Universit\u00e9 Paris-Saclay, Institut Gustave Roussy ","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/03xjwb503","role":"organisation id"},{"title":"SIREN","uri":"130026024","role":"organisation id"},{"title":"RNSR","uri":"201019083D ","role":"labo id"}]}]},"study_info":{"keywords":[{"keyword":"exposome"},{"keyword":"mode de vie"},{"keyword":"nutrition"},{"keyword":"environment"},{"keyword":"pharmaco-\u00e9pidemiologie"},{"keyword":"g\u00e9n\u00e9tique"},{"keyword":"marqueurs biologiques"}],"topics":[{"topic":"Tumeurs malignes du sein","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/1047754165"}]},{"topic":"Tumeurs malignes du c\u00f4lon","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/1265576634"}]},{"topic":"M\u00e9lanome de la peau","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/488336723"}]},{"topic":"Endom\u00e9triose","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/1838213761"}]},{"topic":"Tumeurs malignes de l'ovaire","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/685124533"}]},{"topic":"Tumeurs malignes du corps de l'ut\u00e9rus","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/959493854"}]},{"topic":"Diab\u00e8te sucr\u00e9 de type 2","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/119724091"}]},{"topic":"Asthme","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/1656445230"}]},{"topic":"Maladie de Parkinson","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/296066191"}]},{"topic":"Maladies de l'appareil circulatoire","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/426429380"}]},{"topic":"Ob\u00e9sit\u00e9","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/149403041"}]},{"topic":"COVID-19","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/1730556128"}]},{"topic":"Tumeur maligne du pancr\u00e9as","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/542147910"}]},{"topic":"Lymphomes de Hodgkin et non Hodgkiniens","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/1891884932"}]},{"topic":"Psoriasis","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/63698555"}]},{"topic":"D\u00e9terminants socio-d\u00e9mographiques et \u00e9conomiques","vocab":"health determinant"},{"topic":"D\u00e9terminants socio-d\u00e9mographiques et \u00e9conomiques : Emploi","vocab":"health determinant"},{"topic":"D\u00e9terminants socio-d\u00e9mographiques et \u00e9conomiques : Niveau d'\u00e9tudes","vocab":"health determinant"},{"topic":"D\u00e9terminants socio-d\u00e9mographiques et \u00e9conomiques : \u00c2ge","vocab":"health determinant"},{"topic":"D\u00e9terminants environnementaux","vocab":"health determinant"},{"topic":"D\u00e9terminants environnementaux : Qualit\u00e9 de l'air","vocab":"health determinant"},{"topic":"D\u00e9terminants environnementaux : Climat","vocab":"health determinant"},{"topic":"D\u00e9terminants environnementaux : Autre","vocab":"health determinant"},{"topic":"D\u00e9terminants li\u00e9s au syst\u00e8me de sant\u00e9","vocab":"health determinant"},{"topic":"D\u00e9terminants li\u00e9s au syst\u00e8me de sant\u00e9 : Consommation des soins","vocab":"health determinant"},{"topic":"D\u00e9terminants comportementaux","vocab":"health determinant"},{"topic":"D\u00e9terminants comportementaux : Alimentation","vocab":"health determinant"},{"topic":"D\u00e9terminants comportementaux : Activit\u00e9 physique","vocab":"health determinant"},{"topic":"D\u00e9terminants biologiques","vocab":"health determinant"},{"topic":"D\u00e9terminants biologiques : Pr\u00e9disposition g\u00e9n\u00e9tique","vocab":"health determinant"},{"topic":"D\u00e9terminants biologiques : Viellissement","vocab":"health determinant"},{"topic":"D\u00e9terminants biologiques : Sexe","vocab":"health determinant"}],"purpose":"Recherche de facteurs de risque (mode de vie, alimentation, environnement, ant\u00e9c\u00e9dents familiaux, facteurs reproductifs, traitements...) des cancers et des principales pathologies chroniques chez la femme.","abstract":"La cohorte E3N constitue le socle historique de la cohorte familiale fran\u00e7aise E3N-G\u00e9n\u00e9rations.\r\n\r\nE3N est une \u00e9tude de cohorte prospective qui suit 98 995 femmes fran\u00e7aises n\u00e9es entre 1925 et 1950. \r\n\r\nElle s\u2019int\u00e9resse \u00e0 l\u2019impact du mode de vie, de l\u2019alimentation, de l\u2019environnement et des traitements sur la sant\u00e9 des femmes. Les grandes pathologies chroniques que sont le cancer, le diab\u00e8te, les maladies cardiovasculaires sont particuli\u00e8rement \u00e9tudi\u00e9es.\r\n\r\n Depuis 1990, les femmes E3N remplissent et renvoient des questionnaires papier, tous les 3 ans environ. Elles sont interrog\u00e9es sur leur mode de vie (alimentation, activit\u00e9 physique, s\u00e9dentarit\u00e9, tabac, alcool, prise de m\u00e9dicaments, de traitements hormonaux, etc.), leur environnement et sur l'\u00e9volution de leur \u00e9tat de sant\u00e9 physique et mental.\r\n\r\nLes traitements m\u00e9dicaux sont enrichis par les donn\u00e9es de remboursement de la MGEN. Les pathologies auto-rapport\u00e9es sont valid\u00e9es et d\u00e9taill\u00e9es gr\u00e2ce \u00e0 la collaboration des m\u00e9decins traitants, des laboratoires d'anatomo-pathologie et des \u00e9tablissements d'hospitalisation.\r\n\r\n Les informations de leurs questionnaires sont compl\u00e9t\u00e9es par des donn\u00e9es biologiques : 25 000 femmes E3N ont effectu\u00e9 un pr\u00e9l\u00e8vement sanguin et 47 000 ont fourni un pr\u00e9l\u00e8vement salivaire.\r\n\r\nGr\u00e2ce \u00e0 la fid\u00e9lit\u00e9 et \u00e0 la constance des femmes E3N, la participation \u00e0 l\u2019\u00e9tude continue d\u2019\u00eatre tr\u00e8s \u00e9lev\u00e9e, m\u00eame 35 ans apr\u00e8s l\u2019inclusion. Les donn\u00e9es de l\u2019\u00e9tude, r\u00e9guli\u00e8rement actualis\u00e9es, d\u00e9taill\u00e9es, pr\u00e9cises et valid\u00e9es, permettent \u00e0 l\u2019\u00e9quipe de recherche de mener des travaux d\u2019une excellente qualit\u00e9 scientifique. \r\n\r\nLa cohorte E3N constitue le socle historique de la cohorte familiale E3N-G\u00e9n\u00e9rations, qui la prolonge en invitant les enfants, les p\u00e8res de ces enfants et les petits-enfants des femmes E3N \u00e0 participer \u00e0 leur tour. ","coll_dates":[{"start":"1990-01-01","end":"2035-01-01"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}}],"geog_coverage":"","analysis_unit":"Individus","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D005260\"\n            },\n            \"value\": \"F\u00e9minin\"\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D008875\"\n            },\n            \"value\": \"Adulte (45 \u00e0 64 ans)\"\n        },\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D000368\"\n            },\n            \"value\": \"Personne \u00e2g\u00e9e (65 \u00e0 79 ans)\"\n        },\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D000369\"\n            },\n            \"value\": \"Grand \u00e2ge (80 ans et plus)\"\n        }\n    ],\n    \"level_type_clusion_I\": \"Population g\u00e9n\u00e9rale\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"Femmes n\u00e9es entre 1925 et 1950, affili\u00e9es \u00e0 la MGEN et r\u00e9sidant en France m\u00e9tropolitaine au moment de l'inclusion en 1990\",\n    \"clusion_E\": \"\"\n}","data_kind":"['Donn\u00e9es cliniques','Donn\u00e9es biologiques','Donn\u00e9es socio-d\u00e9mographiques','Donn\u00e9es environnementales \/ d'exposition','Donn\u00e9es comportementales','Donn\u00e9es g\u00e9ospatiales','Donn\u00e9es \u00e9conomiques','Donn\u00e9es g\u00e9n\u00e9tiques \/ g\u00e9nomiques','Donn\u00e9es de sant\u00e9 rapport\u00e9es par les participants de l'\u00e9tude']","quality_statement":{"standards":[{"name":"['CIM 10']","committee":"Le comit\u00e9 institutionnel r\u00e9unit les partenaires fondateurs de la cohorte : Universit\u00e9 Paris-Saclay, Inserm, Gustave Roussy, Ligue Nationale contre le Cancer et la MGEN. Il a pour missions principales de : valider les orientations strat\u00e9giques, suivre l'avancement de la cohorte et sa situation budg\u00e9taire \/ approuver la gestion budg\u00e9taire, les comptes et les rapports annuels d\u2019activit\u00e9 \/ pr\u00e9voir les modalit\u00e9s d'\u00e9valuation de la cohorte et d\u00e9cider son \u00e9ventuelle interruption ou sa prorogation \/ adopter une Charte d\u2019acc\u00e8s aux donn\u00e9es et aux \u00e9chantillons de la cohorte. Le conseil scientifique, compos\u00e9 d'experts internationaux, veille quant \u00e0 lui \u00e0 la pertinence et \u00e0 la qualit\u00e9 scientifique des recherches r\u00e9alis\u00e9es \u00e0 partir des donn\u00e9es et des \u00e9chantillons de la cohorte ; il incite \u00e0 des collaborations en recensant les comp\u00e9tences et les savoirs-faire, et il donne un avis sur la Charte d'acc\u00e8s aux donn\u00e9es.","governance":""}],"other_quality_statement":""}},"study_development":{"development_activity":[{"activity_type":"primary evaluation","activity_description":"\u00c9v\u00e9nements de sant\u00e9\/morbidit\u00e9\r\n\u00c9v\u00e9nements de sant\u00e9\/mortalit\u00e9\r\nConsommation de soins\/services de sant\u00e9\r\nQualit\u00e9 de vie\/sant\u00e9 per\u00e7ue"},{"activity_type":"secondary evaluation","activity_description":""}]},"method":{"data_collection":{"time_method":"Longitudinale prospective","frequency":"Tous les 3 ans environs","sampling_procedure":"['{\"concept\":{\"vocab\":\"CESSDA\",\"vocabURI\":\"Other\"},\"value\":\"Autre\"}']","sample_frame":{"frame_unit":{"unit_type":"['Base m\u00e9dico-administrative (de patients, Assurance Maladie\/Mutuelle)']"}},"coll_mode":["{\"concept\":{\"vocab\":\"CESSDA\",\"vocabURI\":\"Interview\"},\"value\":\"Entretien avec le participant (dont clinique)\"}","{\"concept\":{\"vocab\":\"CESSDA\",\"vocabURI\":\"SelfAdministeredQuestionnaire\"},\"value\":\"Questionnaire auto-administr\u00e9\"}"],"research_instrument":"Acc\u00e8s restreint sur projet sp\u00e9cifique","sources":[{"sourceCitation":{"titlStmt":{"titl":"Base de remboursement de soins de la MGEN"},"holdings":"","notes":{"subject":"source purpose","value":"Enrichissement des donn\u00e9es par croisement (autre que le suivi passif)"}},"srcOrig":["Base m\u00e9dico-administrative"]},{"sourceCitation":{"titlStmt":{"titl":"CepiDC"},"holdings":"","notes":{"subject":"source purpose","value":"Suivi passif des participants"}},"srcOrig":["Base m\u00e9dico-administrative"]}],"target_sample_size":">= 20000 individus","response_rate":"98 995"},"method_notes":"Etude observationnelle","study_class":"\u00c9tude en cours","notes":[{"subject":"research type","values":["Etude observationnelle"]},{"subject":"observational study method","values":["Cohorte"]},{"subject":"follow-up","values":["Suivi par contact avec le participant (t\u00e9l\u00e9phone, e-mail, courrier...)"]}]},"data_access":{"dataset_availability":{"access_place":"sur les serveurs s\u00e9curis\u00e9s de Gustave Roussy","complete":"","status":"{\"extLink\":{\"title\":\"COAR\",\"uri\":\"http:\/\/purl.org\/coar\/access_right\/c_16ec\"},\"value\":\"Acc\u00e8s r\u00e9serv\u00e9\"}"},"dataset_use":{"restrictions":"","conditions":"Modalit\u00e9s d'acc\u00e8s aux donn\u00e9es pour des \u00e9quipes ext\u00e9rieures : demande d'autorisation au comit\u00e9 d'acc\u00e8s aux donn\u00e9es de l'\u00e9tude E3N-G\u00e9n\u00e9rations","conf_dec":[{"txt":"Charte d'acc\u00e8s aux donn\u00e9es "}],"spec_perm":[{"txt":"https:\/\/demande-acces-donnees.portail-fresh.fr\/cohortes\/2\/cohortesDetails","required":"Oui"}],"contact":[{"name":"Elodie;SPEYER","firstname":"Elodie","lastname":"SPEYER","email":"elodie.speyer@inserm.fr"}],"deposit_req":"oui","cit_req":"oui"},"notes":""}},"additional":{"IsImport":false,"versionLang":"fr","originLang":"fr","lastUpdatedAuto":"09-07-2026","lastUpdatedManual":"09-07-2026","autoTranslation":false,"status":"Envoy\u00e9e pour publication","respValidation":"","isHealthTheme":false,"isContributorPI":false,"addTeamMember":false,"primaryInvestigator":{"isPIContact":false,"piMail":"gianluca.severi@inserm.fr","piAffiliation":{"piLabo":"Centre de Recherche en \u00c9pid\u00e9miologie et Sant\u00e9 des Populations (CESP) - \u00c9quipe Exposome et H\u00e9r\u00e9dit\u00e9\r\n\r\nInserm, Universit\u00e9 Paris-Saclay, Institut Gustave Roussy "}},"relatedDocument":[{"type":"Publication r\u00e9utilisant les donn\u00e9es collect\u00e9es dans le cadre de cette \u00e9tude","title":"Description de la cohorte E3N-G\u00e9n\u00e9rations","link":"https:\/\/portail-fresh.fr\/catalogue-detail\/FRESH-PEF3101-fr\/"}],"contactPointLabo":"Centre de Recherche en \u00c9pid\u00e9miologie et Sant\u00e9 des Populations (CESP) - \u00c9quipe Exposome et H\u00e9r\u00e9dit\u00e9\r\n\r\nInserm, Universit\u00e9 Paris-Saclay, Institut Gustave Roussy ","obtainedAuthorization":{"otherAuthorizingAgency":["",""]},"regulatoryRequirements":{"conformityDeclaration":"MR-001"},"fundingAgent":{"fundingAgentType":["Public (France)","Priv\u00e9 \u00e0 but non lucratif","Priv\u00e9 \u00e0 but non lucratif","Public (France)","Priv\u00e9 \u00e0 but non lucratif","Public (France)"],"otherFundingAgentType":["","","","","",""]},"sponsor":{"sponsorType":["Priv\u00e9 \u00e0 but non lucratif","Public (France)","Public (France)"],"otherSponsorType":["","",""]},"governance":{"committee":true},"collaborations":{"networkConsortium":true},"theme":{"complementaryInformation":"","RareDiseases":false},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":false,"allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[{"name":"mode de vie","type":"Comportementale","typeOther":""},{"name":"alimentation","type":"Comportementale","typeOther":""},{"name":"environnement","type":"Sant\u00e9 publique","typeOther":""},{"name":"traitements","type":"M\u00e9dicament","typeOther":""},{"name":"ant\u00e9c\u00e9dents familiaux","type":"G\u00e9n\u00e9tique","typeOther":""},{"name":"exposome","type":"Sant\u00e9 publique","typeOther":""}],"cohortLongitudinal":{"recrutementTiming":[]},"otherResearchType":{"otherResearchTypeDetails":""},"inclusionGroups":[],"nrInclusionGroups":false,"collectionProcess":{"collectionModeDetails":"Auto questionnaire \u00e0 l'inclusion puis tous les trois ans au cours du suivi : recueil de donn\u00e9es sur l'\u00e9tat de sant\u00e9 et le mode de vie, plus des questionnaires sp\u00e9cifiques sous la responsabilit\u00e9 d'un chercheur ou pour un projet ancillaires (sur des sous \u00e9chantillons).- Examen clinique pour un sous-\u00e9chantillon de 25 000 femmes de la cohorte: pouls, pression art\u00e9rielle, poids, taille : donn\u00e9es recueillies entre 1994 et 1998 lors de la prise de sang.- Questionnaire au m\u00e9decin traitant en cas de pathologie d\u00e9clar\u00e9e par la femme: confirmation et compte-rendu anatomopathologique pour plus de 80% des cancers.","collectionModeOther":""},"dataCollection":{"inclusionStrategy":[],"samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"activeFollowUp":{"isActiveFollowUp":true,"followUpModeOther":""},"dataCollectionIntegration":{"isDataIntegration":true},"geographicalCoverage":{"geoDetail":"France"},"dataTypes":{"clinicalDataDetails":"Compte-rendus d'anatomopathologie et\/ou des dossiers d'hospitalisation pour valider et pr\u00e9ciser les pathologies auto-d\u00e9clar\u00e9es","biologicalDataDetails":"Dans le cadre d'\u00e9tudes cas-t\u00e9moin : taux hormonaux, statut vitaminique, biomarqueurs, contaminants...","isDataInBiobank":true,"biobankContent":["Sang total","Plasma","S\u00e9rum","Autres liquides ou s\u00e9cretions biologiques"],"biobankContentOther":"","dataTypeOther":"","paraclinicalDataOther":"","otherLiquidsDetails":"salive"},"variableDictionnary":{"variableDictionnaryAvailable":true,"variableDictionnaryLink":"Disponible prochainement"},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":false,"mockSampleLocation":""},"thirdPartySource":{"otherSourceType":["",""]},"fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}